We are inviting one consortium application for the evaluation of treatments for brain tumours. Across a network of trials, aligned along a pathway of care and with shared infrastructure and systems, the consortium will efficiently undertake studies seeking to evaluate potential treatments. The consortium will also aim to build research capacity and capability, address disparities in research participation for people with brain tumours, and take a coordinated approach to collaborating with industry.
This opportunity has a broad scope encompassing all types of brain tumours, including adult and paediatric brain cancers, metastatic and recurrent disease, low-grade or ‘benign’ and high-grade tumours, and the evaluation of all relevant technology types.
We are inviting expressions of interest to:
- identify those who wish to nominate themselves as the Lead Applicant for the Consortium. There will be a maximum of two joint Lead Applicants. (Please note, applicants who do not nominate themselves as Lead or who are unsuccessful may still be a co-applicant, and the lead CI of a trial within the consortium.)
- attend a workshop to inform and begin the development of this application. It is expected that attendees will include existing brain tumour researchers, those from other fields who may be able to contribute expertise, and industry.
To express an interest in leading the application, please submit our National consortium to evaluate treatments for brain tumours - Expression of Interest for lead form and send to crossprogramme@nihr.ac.uk, by 1pm, 11 October. You do not need to apply to attend the workshop separately.
To apply to attend the workshop and collaborate on the application, please complete our National consortium to evaluate treatments for brain tumours - Expression of Interest to attend workshop form and send to crossprogramme@nihr.ac.uk, by 1pm, 11 October.
Please read the specification document for further details.
Webinar
A webinar for this call is planned for 27 September at 11:30am to 12:30pm. To register, please email crossprogramme@nihr.ac.uk stating your interest in registering to attend the webinar for ‘A national consortium to evaluate treatments for brain tumours’.